Sources | Names Used |
---|---|
GDSC1000, FIMM | Cytarabine |
CTRPv2 | cytarabine hydrochloride |
PharmacoGx | Cytarabine |
Database | Identifier |
---|---|
Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
Pubchem: | 5351180 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-18 |
mRNA | RAG1 | GDSC1000 | pan-cancer | AAC | 0.29 | 9e-16 |
mRNA | RAG2 | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-15 |
mRNA | SLFN11 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-22 |
mRNA | LBR | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-18 |
mRNA | CDCA7 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-19 |
mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-18 |
mRNA | TGIF1 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-11 |
mRNA | CTCF | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-18 |
mRNA | DCK | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-17 |